×
This is the option to test an antibody in special discounted price before purchasing a larger quantity, which gives you more freedom in your projects.
Browse our Product Catalog 2020 here through and order samples below.
Also your local HyTest sales contact North America, Sales Manager Ms. Karen
Smith, would be happy to tell you more and she will give you further
detailed information about all of our products.
Check all latest product news here and below more about our key products.
Established in 1994, HyTest Ltd is a recognized
producer of high-quality monoclonal antibodies and antigens for the
diagnostic industry all around the world. Building on a strong
scientific basis, HyTest has become the global market leader in
supplying certain reagents. With several products appointed as the best
in the world. Please see our introduction video below:
Enter your email and get the very latest news from HyTest.
Stay updated on the:
- latest developments
- new products
- special offers
- scientific articles
- HyTest people and
- our other efforts to improve patient outcomes. Subscribe here.
Troponin I and T
Troponins are gold markers for diagnosing acute myocardial infarction and they have been studied for decades by our R&D scientists. Based on this research, we continuously develop new and improved antibodies in order to meet the demands of assay manufacturers so that they can find the best antibodies on their platforms. Learn more.
NT-proBNP
NT-proBNP does not have any known biological activity, but it has half-life that is several times longer compared to BNP. Therefore, it is considered to be a more stable biomarker in clinical samples, as the clinical value of NT-proBNP is similar to that of BNP. HyTest has carried out a considerable amount of research regarding NT-proBNP and offers antibodies and antigen for use in assay development. Learn more.
Lp-PLA2
Lp-PLA2 can be used as a prognostic marker of adverse cardiac-related events. An increase in Lp-PLA2 concentration can predict the development of incident peripheral arterial disease. We provide four monoclonal antibodies and recombinant Lp-PLA2 for assay development. Learn more.
D-dimer
D-dimer is used as a marker of pathological blood coagulation and it is useful, for example, in ruling out the presence of thrombus in pulmonary embolism or deep vein thrombosis. For D-dimer detection, we recommend choosing antibody pairs that equally recognize D-dimer and fibrin degradation products that are present in blood. We provide antibodies and antigen for assay development. Learn more.
Glial fibrillary acidic protein
GFAP has emerged as a promising marker of traumatic brain injury. It can be detected in blood a few hours after head trauma. We have just launched several antibodies (four recommended pairs) for the detection of GFAP from blood samples. Learn more.
Procalcitonin
PCT concentration in blood increases as a response to systemic inflammation and severe bacterial infections, such as sepsis. For the development of PCT immunoassays we offer monoclonal and polyclonal antibodies. Learn more.
Anti-Müllerian hormone
The measurement of AMH can be used in fertility investigations in order to help to predict the response of women to ovarian stimulation, to estimate the time to menopause, and also to diagnose and monitor women with polycystic ovary syndrome. We provide five MAbs and a recombinant antigen for assay development. Learn more.
Beta-amyloid 1–42
β-amyloid 1–42 can be used for diagnostics of Alzheimer’s disease in both the prodromal and dementia stage of the disease, and it is now included in the diagnostic research criteria for Alzheimer’s disease. We provide well-characterized human beta-amyloid-specific MAbs for the detection of β-amyloid 1–42. Learn more.
Copyright © Hytest Ltd.